Recruiting

Observational Study

Sponsor:

Sameem M. Abedin, MD

Code:

NCT05802069

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The study is an observational trial for patients undergoing cancer-related interventions and therapy at Medical College of Wisconsin Cancer Center. Projects under this protocol will use patient data that will be collected both retrospectively and prospectively. It will also enable prospective sample collection for specific cancer-related studies.

Conditions

Cancer

Study ID

NCT05802069

Start date

Dec 19, 2022

Status verified date

Aug, 2025

Completion date

Dec, 2027

Anticipated

Primary completion date

Dec, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Subjects aged 18 years and older who were previously or are currently receiving care for a cancer-related condition at MCW/FH.

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Number of subjects receiving precision therapies providing biospecimens of any kind. [ Time Frame: One year ]
  • Number of subjects not receiving precision therapies and providing biospecimens. [ Time Frame: One year ]

Central Contacts and Locations

Central contacts

Kristina Jacobs

414-955-3643kjacobs@mcw.edu

Medical College of Wisconsin Cancer Center Clinical Trials Office

866-680-0505cccto@mcw.edu

Locations

Froedtert Hospital and the Medical College of Wisconsin

Recruiting

Milwaukee, Wisconsin, United States, 53226

Contacts

Kristina Jacobs

414-955-3643kjacobs@mcw.edu

More Information

Sponsor

Sameem M. Abedin, MD

Last update posted

Aug 17, 2025

Last verified

Aug, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Sameem M. Abedin, MD on 2025-08-17.